Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lacteol Fort
- Development stage
- Unknown
- Lead developer
- TPG Capital
- Modality
- Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
Lacteol Fort is a probiotic preparation containing lyophilized heat-killed *Lactobacillus acidophilus* LB as its active ingredient. It is manufactured by Rameda Pharmaceutical Company in Egypt under license from Axcan Pharma. While traditionally indicated for the treatment of diarrhea, it is currently being evaluated in a Phase 3 randomized clinical trial led by Ain Shams University for its potential to mitigate antipsychotic-induced weight gain in adult patients with schizophrenia. The therapeutic approach is based on the modulation of the gut microbiome, which has been implicated in the metabolic side effects and weight gain associated with atypical antipsychotic medications.
- Brand names
- Lacteol Fort
- Other names
- Lactobacillus acidophilus LBheat-killed Lactobacillus acidophilus LBlyophilized heat-killed Lactobacillus acidophilus LB
Beyond the preview
Go deeper on Lacteol Fort.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lacteol Fort.